文献
J-GLOBAL ID:201202223198596520
整理番号:12A0729314
再発又は転移性婦人科癌肉腫及び子宮平滑筋肉腫患者におけるアフリベルセプト(VEGF Trap)単剤の第II相試験。Princess Margaret病院,シカゴ及びカリフォルニアの癌第II相コンソーシアムの試験
A phase II study single agent of aflibercept (VEGF Trap) in patients with recurrent or metastatic gynecologic carcinosarcomas and uterine leiomyosarcoma. A trial of the Princess Margaret Hospital, Chicago and California Cancer Phase II Consortia
著者 (12件):
MACKAY H.J.
(Princess Margaret Hospital, ON, CAN)
,
CORREA R.
(Princess Margaret Hospital, ON, CAN)
,
WANG L.
(Princess Margaret Hospital, ON, CAN)
,
POLINTAN R.
(Princess Margaret Hospital, ON, CAN)
,
OZA A.M.
(Princess Margaret Hospital, ON, CAN)
,
BUCKANOVICH R.J.
(Univ. Michigan, MI, USA)
,
HIRTE H.
(Juravinski Cancer Centre, ON, CAN)
,
HOSKINS P.
(BC Cancer Agency Vancouver Clinic, BC, CAN)
,
BIAGI J.
(Cancer Centre of Southeastern Ontario, ON, CAN)
,
MARTIN L.P.
(Fox Chase Cancer Center, PA, USA)
,
FLEMING G.F.
(Univ. Chicago, IL, USA)
,
MORGAN R.
(City of Hope, CA, USA)
資料名:
Gynecologic Oncology
(Gynecologic Oncology)
巻:
125
号:
1
ページ:
136-140
発行年:
2012年04月
JST資料番号:
E0561C
ISSN:
0090-8258
資料種別:
逐次刊行物 (A)
発行国:
オランダ (NLD)
言語:
英語 (EN)